BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18439425)

  • 1. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
    Feld JJ; Hussain N; Wright EC; Kleiner DE; Hoofnagle JH; Ahlawat S; Anderson V; Hilligoss D; Gallin JI; Liang TJ; Malech HL; Holland SM; Heller T
    Gastroenterology; 2008 Jun; 134(7):1917-26. PubMed ID: 18439425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic abnormalities in patients with chronic granulomatous disease.
    Hussain N; Feld JJ; Kleiner DE; Hoofnagle JH; Garcia-Eulate R; Ahlawat S; Koziel DE; Anderson V; Hilligoss D; Choyke P; Gallin JI; Liang TJ; Malech HL; Holland SM; Heller T
    Hepatology; 2007 Mar; 45(3):675-83. PubMed ID: 17326162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute portal hypertension associated with liver resection. Analysis of early postoperative death.
    Kanematsu T; Takenaka K; Furuta T; Ezaki T; Sugimachi K; Inokuchi K
    Arch Surg; 1985 Nov; 120(11):1303-5. PubMed ID: 4051735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal and Hepatic Manifestations of Chronic Granulomatous Disease.
    Yang AH; Sullivan B; Zerbe CS; De Ravin SS; Blakely AM; Quezado MM; Marciano BE; Marko J; Ling A; Kleiner DE; Gallin JI; Malech HL; Holland SM; Heller T
    J Allergy Clin Immunol Pract; 2023 May; 11(5):1401-1416. PubMed ID: 36646382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
    Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
    Eslam M; Ampuero J; Jover M; Abd-Elhalim H; Rincon D; Shatat M; Camacho I; Kamal A; Lo Iacono O; Nasr Z; Grande L; Banares R; Khattab MA; Romero-Gomez M
    Ann Hepatol; 2013; 12(4):588-98. PubMed ID: 23813137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis.
    Lim YL; Choi E; Jang YO; Cho YZ; Kang YS; Baik SK; Kwon SO; Kim MY
    Gut Liver; 2016 Jan; 10(1):109-16. PubMed ID: 25963087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
    Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver involvement in systemic lupus erythematosus: case review of 40 patients.
    Chowdhary VR; Crowson CS; Poterucha JJ; Moder KG
    J Rheumatol; 2008 Nov; 35(11):2159-64. PubMed ID: 18793002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
    Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
    Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated at a Single Center.
    Strongin A; Heller T; Doherty D; Glass IA; Parisi MA; Bryant J; Choyke P; Turkbey B; Daryanani K; Yildirimli D; Vemulapalli M; Mullikin JC; Malicdan MC; Vilboux T; Gahl WA; Gunay-Aygun M;
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):428-435. PubMed ID: 29112083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Venous Pressure Gradient Measurements in Children: Correlation With Hepatic Histology and Clinical Indicators of Portal Hypertension.
    Ebel NH; Carlin K; Shaffer ML; Shivaram G; Hawkins M; Lane ER; Cooper K; Lindquester WS; Gadodia G; Murray KF
    J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):788-792. PubMed ID: 30921261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal involvement in chronic granulomatous disease.
    Marciano BE; Rosenzweig SD; Kleiner DE; Anderson VL; Darnell DN; Anaya-O'Brien S; Hilligoss DM; Malech HL; Gallin JI; Holland SM
    Pediatrics; 2004 Aug; 114(2):462-8. PubMed ID: 15286231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic portal venopathy and related disorders of the liver.
    Chawla Y; Dhiman RK
    Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.